Ikarian Capital’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,016
| Closed | -$13.7K | – | 126 |
|
|
2024
Q4 | $13.7K | Buy |
+6,016
| New | +$13.7K | ﹤0.01% | 117 |
|
|
2024
Q3 | – | Sell |
-6,016
| Closed | -$30.5K | – | 106 |
|
|
2024
Q2 | $30.5K | Hold |
6,016
| – | – | 0.01% | 84 |
|
|
2024
Q1 | $51K | Hold |
6,016
| – | – | 0.01% | 76 |
|
|
2023
Q4 | $24.6K | Hold |
6,016
| – | – | ﹤0.01% | 75 |
|
|
2023
Q3 | $18.1K | Sell |
6,016
-6,646
| -52% | -$19.9K | ﹤0.01% | 78 |
|
|
2023
Q2 | $391K | Hold |
12,662
| – | – | 0.06% | 63 |
|
|
2023
Q1 | $627K | Hold |
12,662
| – | – | 0.14% | 66 |
|
|
2022
Q4 | $311K | Hold |
12,662
| – | – | 0.08% | 51 |
|
|
2022
Q3 | $839K | Sell |
12,662
-4,233
| -25% | -$280K | 0.17% | 39 |
|
|
2022
Q2 | $698K | Sell |
16,895
-3,382
| -17% | -$140K | 0.13% | 57 |
|
|
2022
Q1 | $1.02M | Buy |
20,277
+974
| +5% | +$49.1K | 0.13% | 69 |
|
|
2021
Q4 | $1.16M | Hold |
19,303
| – | – | 0.17% | 67 |
|
|
2021
Q3 | $955K | Sell |
19,303
-244
| -1% | -$12.1K | 0.07% | 95 |
|
|
2021
Q2 | $1.12M | Hold |
19,547
| – | – | 0.09% | 106 |
|
|
2021
Q1 | $1.12M | Buy |
+19,547
| New | +$1.12M | 0.04% | 126 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 148 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 114 |
|